Opera's latest update brings all sorts of organizational updates to its One browser, alongside contextual AI that enhances ...

The newest version of Opera One improves on the interesting Tab Islands feature, brings a re-engineered AI assistant, and ...

The program will fast-track residency and citizenship for wealthy immigrants. President Donald Trump announced that his "gold card" immigration plan has officially launched – a system the ...

Caltrans says Regent’s Slide on Highway 1 might reopen before March 30. Crews first must finish mesh, culvert, barriers, paving and a final roadway assessment. As always, reopening remains ...

This is read by an automated voice. Please report any issues or inconsistencies here. China’s trade surplus reached $1 trillion in 2025 for the first time, driven by strong November exports that ...

China's exports to the United States dropped sharply this year in the face of President Trump's tariffs — but the country is still finding plenty of customers elsewhere around the world. Customs data ...

President Trump’s tariffs weren’t enough to hold back the global export flood by China, which pushed past last year’s record in just 11 months. By Keith Bradsher Reporting from Beijing China got the ...

The FDA’s reported plan to move toward single-trial approvals has stirred industry concern, but one group of analysts views the proposal as a catalyst for greater R&D investment in the sector. Earlier ...

Employers have cut more than 1.1 million jobs through November, the most since 2020, when companies laid off 2.2 million workers as the pandemic was slamming the U.S. economy, according to a new ...

The World Health Organization on Monday recommended GLP-1 drugs as a tool to manage obesity in adults, marking a shift in the way the U.N. agency has historically framed obesity treatment. The WHO ...

CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, is co-author of "Whatever Happened to Pudding Pops? The Lost Toys, Tastes and Trends of the '70s and '80s," as well as "The ...

Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral semaglutide failed to slow down Alzheimer's progression Endocrinologist Daniel ...